A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma

NCT01908777 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
47
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators